Bovine Heparin Demonstrates the Same Interaction with HIT Antibodies As Porcine Heparin

肝素 血小板因子4 抗凝剂 肝素诱导血小板减少症 医学 抗体 血小板 药理学 化学 免疫学 外科
作者
Jeanine M. Walenga,Walter Jeske,Sabrina Bertini,Giulia Risi,Michelle Sung,Ambar Farooqui,Cassie Bacher,Debra Hoppensteadt,Omer Iqbal,Bruce Lewis,Mamdouh Bakhos
出处
期刊:Blood [Elsevier BV]
卷期号:134 (Supplement_1): 2351-2351
标识
DOI:10.1182/blood-2019-127304
摘要

Heparin, an anticoagulant widely used in numerous medical applications, is considered an essential medicine by the WHO. Due to its high volume use and that it is the parent material for low molecular weight heparins, there is potential for the raw material to be in short supply. The African swine fever epidemic in China, ongoing since August 2018, has added further restraints on heparin source material supply. At present medical grade heparin in the US is only derived from porcine intestinal mucosa; however, there are explorations into using bovine, ovine, and other sources. Bovine heparin, once common place in the US pharmaceutical sector, is again under consideration by the US FDA. This study focused on the primary immunogenic activity associated with heparin, that is heparin-induced thrombocytopenia (HIT), and how the interaction of bovine heparin with functional HIT antibodies compares to that of porcine heparin. Materials and Methods Bovine unfractionated heparin from multiple manufacturers was compared to commercial medical grade porcine heparin obtained from US pharmacies. The US Pharmacopeia porcine heparin standard was used to determine potency equivalence. Antibodies to the complex of platelet factor 4/heparin (PF4/heparin) from banked clinically confirmed HIT patient apheresis fluids were combined with heparin and donor platelet rich plasma (PRP; blood collected in citrate from volunteers after signing a consent document). Heparins were tested at final concentrations of 0.1, 0.4, 0.8, 1, and 100 U/mL. The platelet activation response was determined on the BioData PAP-8 Platelet Aggregometer and quantitated in terms of primary slope (PS), area under the curve (AUC), maximum aggregation (MA), and final aggregation (FA). Characterization of the biophysical interaction between varying molar ratios of human PF4 and heparin was performed using photon correlation spectroscopy (PCS) and zeta potential (Zp) measurements of PF4/heparin complexes using Zetasizer Nano ZS instrumentation and software. Differences between bovine and porcine heparin were assessed by t-test or Mann-Whitney test. Concentration-response curves were analyzed by two-way ANOVA followed by the Holm-Sidak multiple comparison test using SigmaPlot software. Results Platelet activation to PF4/heparin antibodies at bovine and porcine heparin concentrations of 0.1 U/mL (56 ± 9 % vs. 54 ± 11 % MA) and 0.4 U/mL (59 ± 10 % vs. 65 ± 8 % MA) were the same with the expected inhibition (9 ± 4% MA) at the supra-therapeutic concentration of 100 U/mL. Consistent responses were obtained across 21 lots of bovine heparin, 30 lots of porcine heparin, and 38 platelet-HIT antibody combinations. The HIT potential of bovine heparin and porcine heparin was not statistically different (p>0.05). At higher medical use doses, the platelet aggregation response in the presence of HIT antibodies was actually lower for bovine heparin than porcine heparin (0.8 U/mL, 49 ± 10 % vs. 64 ± 9 % MA, p<0.05; and 1.0 U/mL, 45 ± 11 % vs. 62 ± 9 % MA, p<0.05). By PCS, it was observed that the maximal aggregation between PF4 and either porcine or bovine heparin occurred at comparable molar ratios (7.3 ± 1.5 vs. 6.4 ± 0). Although the porcine and bovine heparins exhibited comparable molecular weights (16,333 ± 153 vs. 16,790 ± 230 Da) and polydispersities (1.19 ± 0.02 vs. 1.15 ± 0.01), porcine heparin formed somewhat larger complexes with PF4 (1113 ± 65 nm) than did bovine heparin (863 ± 68 nm). The molar ratios of PF4 to heparin at which the charge of the complex was fully neutralized (Zp = 0) was comparable for porcine and bovine heparin (9.04 ± 0.19 vs. 9.97 ± 0.65). Consistent responses were obtained across 4 lots of bovine heparin and 3 lots of porcine heparin. Conclusions Bovine heparin and porcine heparin had the same in vitro functional platelet activation response in the presence of HIT antibodies, the same potential to form complexes with human PF4, and the same associated features that make PF4 immunogenic. This investigation demonstrates that bovine heparins should have a similar immunogenic response as porcine heparin at equi-unit dosing. Current refinements in the manufacturing process for bovine and porcine heparins have led to well-characterized and purified products which is reflected in their comparable biological behavior. Disclosures No relevant conflicts of interest to declare.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Eric的应助被雪山大地采纳,获得10
刚刚
1秒前
1秒前
ThanhHuy发布了新的文献求助30
3秒前
Eric的应助被初一采纳,获得10
3秒前
顺利完成签到,获得积分20
3秒前
杨凤艳发布了新的文献求助10
4秒前
烟花的应助被yh采纳,获得10
4秒前
kylian完成签到 ,获得积分10
4秒前
顺利发布了新的文献求助10
6秒前
Gp1983发布了新的文献求助50
6秒前
6秒前
6秒前
笨笨米卡完成签到,获得积分10
7秒前
脑洞疼的应助被抹茶小饼干采纳,获得10
7秒前
Valentina完成签到,获得积分10
7秒前
9秒前
racheeeel完成签到,获得积分10
9秒前
11秒前
Nole的应助被欢乐的兔子采纳,获得10
11秒前
自觉新竹发布了新的文献求助10
11秒前
秋风的应助被土制陶瓷采纳,获得10
11秒前
脑洞疼的应助被大左采纳,获得10
12秒前
晚风发布了新的文献求助10
12秒前
zik发布了新的文献求助10
12秒前
超级无敌的应助被雪山大地采纳,获得10
12秒前
12秒前
在水一方的应助被顺利采纳,获得10
13秒前
嵇老五发布了新的文献求助10
14秒前
英姑的应助被开心德地采纳,获得10
16秒前
满意妙梦完成签到,获得积分10
17秒前
洁净雅彤发布了新的文献求助10
18秒前
笨笨米卡发布了新的文献求助200
18秒前
18秒前
20秒前
wg发布了新的文献求助10
20秒前
哇啦的应助被yang采纳,获得10
21秒前
哇啦的应助被yang采纳,获得10
21秒前
哇啦的应助被yang采纳,获得10
21秒前
罗春的应助被yang采纳,获得10
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8188451
求助须知:如何正确求助?哪些是违规求助? 9576286
关于积分的说明 21846376
捐赠科研通 7786514
什么是DOI,文献DOI怎么找? 3435343
关于科研通互助平台的介绍 2559618
邀请新用户注册赠送积分活动 2482322